Susannah Gray's Insider Trades & SAST Disclosures
Susannah Gray's most recent trade in Morphic Holding Inc was a trade of 23,168 Common Stock done . Disclosure was reported to the exchange on June 4, 2024.
Add Superstar Alert
Note
This is a custom search result for pattern Susannah Gray.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Morphic Holding Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,168 | 23,168 | - | - | Common Stock | |
|
Maravai LifeSciences Holdi...
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 23 May 2024 | 20,645 | 80,768 | - | 10.8 | 222,553 | Class A Common Stock |
|
4D Molecular Therapeutics Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 23,576 | 23,576 | - | - | Share Option (Right to Buy) | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 10,537 | 31,488 (0%) | 0% | 0 | Ordinary Shares | |
|
Maravai LifeSciences Holdi...
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 24,000 | 60,123 | - | 0 | Class A Common Stock | |
|
Morphic Holding Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,535 | 12,535 | - | - | Director Stock Option (Right to Buy) | |
|
4D Molecular Therapeutics Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,044 | 22,044 | - | - | Share Option (Right to Buy) | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,132 | 20,951 (0%) | 0% | 0 | Ordinary Shares | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 28,000 | 28,000 | - | - | Share Option (Right to Buy) | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 10,131 | 10,131 (0%) | 0% | 0 | Ordinary Shares | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 4,666 | 4,666 | - | - | Share Option (Right to Buy) | |
|
Theravance Biopharma Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2023 | 1,688 | 11,819 (0%) | 0% | 0 | Ordinary Shares | |
|
4D Molecular Therapeutics Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
|
Maravai LifeSciences Holdi...
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 4,271 | 36,123 | - | 0 | Class A Common Stock | |
|
Morphic Holding Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
|
4D Molecular Therapeutics Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
|
Morphic Holding Inc
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 24,000 | 24,000 | - | - | Stock Option (right to buy Common Stock) | |
|
Maravai LifeSciences Holdi...
|
Susannah Gray | Director | Purchase of securities on an exchange or from another person at price $ 27.00 per share. | 24 Nov 2020 | 20,000 | 31,852 | - | 27 | 540,000 | Class A Common Stock |
|
Maravai LifeSciences Holdi...
|
Susannah Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 11,852 | 11,852 | - | 0 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges